Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 3, 2021

Primary Completion Date

September 3, 2026

Study Completion Date

September 3, 2026

Conditions
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage IIA Rectal Cancer AJCC v8Stage IIB Rectal Cancer AJCC v8Stage IIC Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8Stage IIIB Rectal Cancer AJCC v8Stage IIIC Rectal Cancer AJCC v8
Interventions
PROCEDURE

Biopsy

Undergo biopsy

PROCEDURE

Biospecimen Collection

Undergo collection of blood and/or tissue samples

OTHER

Electronic Health Record Review

Medical records are reviewed

Trial Locations (2)

97239

RECRUITING

OHSU Knight Cancer Institute, Portland

98109

RECRUITING

Fred Hutch, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Natera, Inc.

INDUSTRY

lead

OHSU Knight Cancer Institute

OTHER

NCT05081024 - Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer | Biotech Hunter | Biotech Hunter